Ionis alexander disease
Web30 sep. 2024 · Alexander disease (AxD) is a rare neurological condition characterized as a leukodystrophy, or a disease affecting the myelin sheath (the fatty insulation that protects a nerve fiber and supports signal conduction). Two major types of AxD … WebAxD is a rare, progressive and fatal neurological disease that affects the myelin sheath which protects nerve fibers. AxD is caused by a gain-of-function mutation in the GFAP …
Ionis alexander disease
Did you know?
Web4 jan. 2024 · BIIB115/ION306 represents another example of our productive collaboration with Biogen to discover and develop medicines that have potential to significantly benefit patients suffering from neurological diseases,” said C. Frank Bennett, Ph.D., Executive Vice President, Chief Scientific Officer and Franchise Leader for Neurological Programs at Ionis. Web20 apr. 2024 · Alexander disease is a rare neurological condition characterized as a leukodystrophy, or a disease affecting the myelin sheath (the fatty insulation that …
Web5 apr. 2024 · Advancement of ION363 to a pivotal trial is the latest example of the power of Ionis' antisense technology to potentially target the root causes of neurological diseases," said C. Frank Bennett ... WebIONIS-FXI RX (BAY2306001) is an antisense oligonucleotide that inhibits the synthesis of coagulation factor XI (FXI) and has been investigated in healthy volunteers and patients with end-stage renal disease (ESRD). FXI-LICA (BAY2976217) shares the same RNA sequence as IONIS-FXI RX …
Web2 okt. 2024 · Developed by Ionis, ION373 is an investigational antisense medicine, designed to stop the mutated gene from producing excess glial fibrillary acidic protein (GFAP), which causes the disease.... Web20 apr. 2024 · Alexander disease is a rare neurological condition characterized as a leukodystrophy, or a disease affecting the myelin sheath (the fatty insulation that protects a nerve fiber and supports...
Web31 dec. 2024 · Alexander disease affects approximately 500 people in the EU. It is caused by a mutation in a protein that creates overproduction of glial fibrillary acidic protein (GFAP) in the brain. ION373 is designed to stop the mutated gene from producing excess GFAP.
Web17 nov. 2024 · Antisense therapy in a rat model of Alexander disease reverses GFAP pathology, white matter deficits, and motor impairment Antisense therapy in a rat model of Alexander disease reverses GFAP pathology, white matter deficits, and motor impairment Sci Transl Med. 2024 Nov 17;13 (620):eabg4711. doi: 10.1126/scitranslmed.abg4711. … greatest senators of the philippinesWebIn addition to Alzheimer's disease, our clinical stage neurology programs include ATTR polyneuropathy, ALS, Alexander disease, Parkinson's disease and Angelman syndrome." The Phase 1b trial and its open-label long-term extension (LTE) were designed to evaluate the safety and tolerability of multiple dose levels of IONIS-MAPTRx in patients with mild … flipping color pythonWeb10 apr. 2024 · Non-alcoholic fatty liver disease (NAFLD) is a common, progressive liver disease strongly associated with the metabolic syndrome. It is unclear how progression of NAFLD towards cirrhosis ... greatest shave 2020WebAbstract Objective: Alexander disease is a fatal leukodystrophy caused by autosomal dominant gain-of-function mutations in the gene for glial fibrillary acidic protein (GFAP), an intermediate filament protein primarily expressed in astrocytes of … greatest shadow legendsWeb20 apr. 2024 · Alexander disease is a rare neurological condition characterized as a leukodystrophy, or a disease affecting the myelin sheath (the fatty insulation that … greatest shave 2018WebAlexander disease is a very rare autosomal dominant leukodystrophy, ... A phase III clinical trial of an antisense therapy, sponsored by Ionis Pharmaceuticals, began in 2024. A bone marrow transplant has been … greatest shave 2019Web17 nov. 2024 · Alexander disease is a progressive and rare neurological disorder with no cure or standard course of treatment. But a new study led by researchers at the University of Wisconsin–Madison involving a rat model of the disease offers a potential treatment for the typically fatal condition. Albee Messing, VMD, PhD flipping columns and rows in excel